-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Downgrades Select Medical Hldgs to Neutral, Lowers Price Target to $16.5

Benzinga·05/13/2026 09:13:31
Listen to the news
Mizuho analyst Ann Hynes downgrades Select Medical Hldgs (NYSE:SEM) from Outperform to Neutral and lowers the price target from $17 to $16.5.